In consequence, PTPIP51 plays a pivotal role in the oncogenesis of breast carcinoma and it is of the utmost interest to unveil the regulations of PTPIP51 in respect of therapy resistance and growth signaling (Figure 2A). The gene discussed is RMDN3; the disease is breast carcinoma.